The Ink4a/Arf locus encodes two structurally unrelated tumor suppressor proteins, p16 INK4a INK4a -cdk4-binding function and required a cAMP-response element/activating transcription factor-2-binding site. p19 ARF repressed cyclin D1 through a novel distal cis-element at ؊1137, which bound p53 in chromatin-immunoprecipitation assays. Transcriptional repression of the cyclin D1 gene through distinct DNA sequences may contribute to the tumor suppressor function of the Ink4a/ Arf locus.
INTRODUCTION
The cyclin D1 gene encodes a labile regulatory subunit of a holoenzyme that phosphorylates and inactivates the pRb retinoblastoma tumor suppressor. Oncogenic signals including Ras, Src, Stat3, and ␤-catenin induce the transcription and abundance of cyclin D1 (1) (2) (3) (4) . Cyclin D1 is overexpressed in more than 30% of human breast cancers and mammary gland-targeted expression of cyclin D1 is sufficient for the induction of mammary tumorigenesis (5) . Conversely the reduction in cyclin D1 abundance using antisense and immunoneutralizing antibodies has demonstrated a requirement for cyclin D1 in proliferative signaling induced by growth factors and hormones in breast cancer epithelial cells (6, 7) . Mice deleted of the cyclin D1 gene are resistant to Ras-and ErbB2-induced mammary tumorigenesis (8) . Antiproliferative agents such as endostatin (9) and pharmaceutical agents with antiproliferative properties including acyclic retinoid, flavoperidol, and phosphatidylinositol 3Ј-kinase inhibitors repress cyclin D1 transcription and abundance leading to cell cycle arrest (10 -12) . The tumor suppressors RASSF1A and the INI1 repressor components of the SWI/SNF complex mediate cell cycle arrest through repression of cyclin D1 (13, 14) . As a common transcriptional target of diverse oncogenic and mitogenic signaling pathways through distinct DNA sequences, cyclin D1 transcription provides the basis for collaborative induction by proliferative pathways (15) . Conversely, transcriptional repression of cyclin D1 by cytostatic molecules serves to integrate in a dynamic manner cell cycle inhibitory effectors.
The complex interplay between tumor-suppressor genes and tumorpromoting genes has been simplified through the almost invariant inactivation of the p53 and the p16 INK4a /retinoblastoma (Rb) pathway in human cancer (16, 17) . Cyclin D1 overexpression provides a common mechanism for disruption of the Rb pathway in human breast cancers. In other tumor types, Rb pathway inactivation may occur as a result of inactivation of Rb through mutation, deletion, or inactivation of Rb function through viral sequestration, phosphorylation, or dysregulation of components controlling Rb phosphorylation (18) . Mutations of G 1 -specific cyclin-dependent kinase catalytic units and/or elimination of inhibitor(s) of cyclin-dependent kinase 4 (INK4) also contribute to the phosphorylation status and inactivation of Rb (16, 17) . The INK4a/ARF locus is involved in both the pRb and p53 pathways encoding p16 INK4a , a regulator of cdk4/6-mediated pRB phosphorylation, and p19 ARF , a modulator of Mdm2-mediated degradation of p53 (19, 20) . Mice deleted of the Ink4/Arf locus are prone to spontaneous tumor formation and have increased susceptibility to oncogenic effects of Ras, Myc, and an activated epidermal growth factor receptor (21) (22) (23) indicating the importance of this locus in tumor suppression in vivo.
Activating signals from ␤-catenin, Src, and the Ras-Raf-MAPK pathway induce INK4a/ARF (24 -27) . Thus common oncogenic signals induce expression of both cyclin and cyclin inhibitors. The fidelity with which INK4a/ARF, induced by oncogenic signals, transduces a tumor suppressor phenotype is of fundamental importance (16, 17) . Ectopic p19 alternative reading frame (ARF) expression stabilizes p53 and induces p53-responsive genes, including the p21 Cip1 gene that contributes to cell cycle arrest in fibroblasts (28) . The molecular targets of INK4a/ARF in mammary epithelial cells are not well understood, although loss of p16
INK4a in breast cancer cells contributes to extended growth capacity (29) , and reintroduction of p16
INK4a into breast cancer epithelial cells induces a dose-dependent cell cycle arrest (30, 31) . Breast cancer cell lines are deleted of p16
INK4a in 40 -60% of cases (32) , and DNA methylation, an alternate mechanism of p16 INK4a inactivation, has been reported to occur in up to 30% of human breast cancers (33, 34) . Reciprocal expression of cyclin D1 and p16
INK4a has been reported in human breast cancer (34) , raising the possibility that p16
INK4a may regulate cyclin D1 abundance. The current studies investigated the function of Ink4a/Arf in mammary epithelial cells and the mechanism of cell cycle arrest. The expression of cyclin D1 is increased in the tissues of Ink4a/Arf ARF through distinct DNA sequences in the promoter. As cyclin D1 abundance is rate-limiting in breast epithelial cell proliferation and tumorigenesis, INK4a and ARF repression of cyclin D1 may contribute to INK4a/ARF tumor suppression function.
EXPERIMENTAL PROCEDURES
Plasmids and Reporter Gene Assays. The luciferase reporter gene constructions for human cyclin D1, cyclin E, cyclin A, c-Fos, c-Jun, JunB, p16
INK4a (6, 35) , and expression vectors for p16 INK4a , pCMVp16 INK4a , pCMVp16
INK4aP114L (36) and pcDNA-p19 ARF were described previously. The region from Ϫ1156 -1117 was deleted in the context of the Ϫ1745 CD1LUC reporter.
Cell culture, DNA transfection, and luciferase assays were performed as described previously (35) . The MCF7 cells were maintained in MEM with 5% FCS and 1% penicillin/streptomycin. Cells were transfected by calcium phosphate precipitation, the media was changed after 3 h, and luciferase activity determined after a further 24 -36 h. Comparison was made between the effect of transfecting active expression vector with the effect of an equal amount of vector cassette. At least three different plasmid preparations of each construct were used. In each experiment, a dose response was determined with 150, 300, or 600 ng of expression vector as indicated in the figure legend (3, 4, 6, 8) and the cyclin D1 promoter reporter plasmids (4.8 g). Luciferase assays were performed at room temperature using an Autolumat LB 953 (EG&G Berthold), and the initial 30 s of the reaction were used to assess luciferase content with the values expressed in arbitrary light units. Background activity from cell extracts was typically Ͻ100 Absolute Light Units/10 s. Statistical analyses was performed using the Mann-Whitney U test, and significant differences were established as P Ͻ 0.05.
Antibodies, Reagents, and Northern and Western Blot Analysis. MCF7 cells were transfected with empty vector or expression plasmids encoding p16
INK4a or p19 ARF along with pMACS4.1 and sorted for transfection using an autoMACS cell sorter (Miltenyi Biotech, Auburn, CA). Cellular extracts were then processed for either Northern or Western blot analysis as describeddeficient previously in this laboratory (11, 35) . Tissues isolated from Ink4a/ Arf-deficient mice, and cells were lysed in buffer containing 50 mM HEPES (pH 7.2), 150 mM NaCl, 1 mM EGTA, 1 mM EDTA, 1 mM DTT, 0.1% Tween 20, 0.1 mM phenylmethylsulfonyl fluoride, 2.5 mg/ml leupeptin, and 0.1 mM Na3VO4. Total protein was determined using the Bradford method (Bio-Rad, Hercules, CA). Lysates (100 g) were separated on 12% SDS-PAGE and blotted onto nitrocellulose. Membranes were blocked with 5% milk in PBS-0.2% Tween 20 for 1 h at room temperature before exposure of primary antibodies to cyclin D1 (AB-3; NeoMarkers, Fremont, CA), p16
INK4a , p19 ARF , p53, activating transcription factor-2 (ATF-2), cAMP-responsive elementbinding protein (CREB; Santa Cruz Biotechnology, Santa Cruz, CA), or guanine dissociation inhibitor (a gift from Dr. P. Bickel). Membranes were washed extensively in PBS-0.2% Tween 20 and incubated with appropriate secondary antibodies conjugated to horseradish peroxidase (Santa Cruz Biotechnology). Membranes were washed extensively with PBS-0.2% Tween 20, and proteins were visualized using chemiluminescence. Fold increase in protein levels were plotted against a standard of 293T cells transfected with the expression vector for the relevant protein.
Flow Cytometric Analyses. Selection of transfected cells using the CD4 as a marker was performed as described previously using magnetic activated cell sorting (MACS; Ref. 37) . Flow cytometric analyses were carried out in a fluorescence-activated cell sorter (FACStar plus; Becton Dickinson) with a 360 -365 nM argon-iron laser (38) . Histograms were analyzed for cell cycle compartments using ModFit version 2.0 (Verity Software House, Topsham, ME). To select transfected cells, cotransfection experiments were conducted using magnetic separation of transfected cells using CD4 as the marker and the MACS. A comparison was made between cells transfected with vector encoding p16 INK4a , p19 ARF expression plasmid, and cells transfected with empty expression vector cassette. Cells were stained with cell-permeable DNAbinding dye Hoechst 33342 (10 mg/ml) for 2 h before harvesting, and all subsequent solutions contained Hoechst 33342. Cells were harvested 48 h after transfection using EDTA (5 mg/ml) in PBS. Cells were pelleted by centrifugation and resuspended in PBS containing anti-CD4-coated magnetic beads. Cells were incubated with beads for 20 min, and CD4-positive cells were obtained using a separating column. Cell cycle analysis was performed in a flow cytometer with a 360 -365 nM argon-iron laser. Western blotting was performed on the cells as described above (39) .
Ink4a/Arf ؊/؊ Mice. The Ink4a/Arf knockout mice, with portions of exons 2 and 3 replaced by a neo cassette (40) , were established in the Friends virus B strain through 11 back-crossings. Mice were screened by PCR for the Ink4a/Arf genomic status. DNA was extracted by standard methods from a small piece of tail tissue cut from each animal at the time of weaning (41) . For evaluating the Ink4a/Arf status of offspring, PCR reactions using three primers allowed for simultaneous detection of both the normal and mutant p16 INK4a allele in a single reaction. These primers consisted of a common 5Ј sense primer, p16 -1F (5ЈTCCCTCTACTTTTTCTTCTGAC-3Ј); two 3Ј antisense primers, p16 -1R (5ЈCGGAACGCAAATATCGCAC-3Ј); and p16-Nul (5Ј-CTAGTGAGACGTGCTACTTC-3Ј). Reactions were run for 30 cycles of 94°C for 1 min, 55°C for 1 min, and 72°C for 1 min. Mouse embryo fibroblasts were prepared from Ink4a/Arf Ϫ/Ϫ or wild-type litter mate controls as described previously (11) .
Chromatin Immunoprecipitation (ChIP) Assay. ChIP analysis was performed following a protocol provided by Upstate Biotechnology under modified conditions. MCF7 cells (1 ϫ 10 6 ) were grown in DMEM with 10% charcoal stripped dextran serum for 3 days. Upon estradiol (100 nM) stimulation for 45 min, the cells were cross-linked by adding 1.1% formaldehyde buffer containing 100 mM sodium chloride, 1 mM EDTA-Na (pH 8.0), 0.5 mM EGTA-Na, and Tris-HCl (pH 8.0) directly to culture medium for 10 min at 37°C. The medium was aspirated, washed thrice using ice-cold PBS containing 10 mM DTT and protease inhibitors, lysed by warm 1% SDS lysis buffer, and incubated for 10 min on ice. The cell lysates were fornicated to shear DNA to lengths between 200 and 1000 bp, and thee samples were diluted to 10-fold in ChIP dilution buffer. To reduce nonspecific background, cell pellet suspension was precleared with 60 l of salmon sperm DNA/protein-A agarose-50% slurry (Upstate Biotechnology) for 2 h at 4°C with agitation. Chromatin solutions were precipitated overnight at 4°C using 4 g of anti-p53 (FL-393; Santa Cruz Biotechnology) with rotation. For a negative control, rabbit IgG was immunoprecipitated by incubating the supernatant fraction for 1 h at 4°C with rotation. Sixty l of salmon sperm DNA/protein-A agarose slurry was added for 2 h at 4°C with rotation to collect the antibody/histone complex and washed extensively following the manufacturer's protocol. Input and immunoprecipitated chromatin were incubated at 65°C overnight to reverse crosslinks. After proteinase K digestion for 1 h, DNA was extracted using Qiagen spin column kit. Precipitated DNAs were analyzed by PCR. ChIP analysis was conducted of either endogenous gene promoters or in a subset of experiments, MCF-7 cells were transiently transfected with plasmid DNAencoding promoter reporter gene constructs, and ChIP analysis was conducted using a reduction in the number of cycles from 30 to 25. The following primers were used for PCR: for mdm2 promoter, 5Ј-TGGGCAGGTTGACT-CAGCTTTTCCTC-3Ј and 5Ј-TGGCGTGCGTCCGTGCCCAC-3Ј; for cyclin D1 promoter, primer pair for ARF-response element site, 5Ј-TCCCCTCTGC-CTGGGACAAG-3Ј and 5Ј-GACCCTCTCATGTAACCACG-3; primer pair for AP-1 site, 5Ј-CTGCCTTCCTACCTTGACCA-3Ј and 5Ј-TGAAGG-GACGTCTACACCCC-3Ј; primer pair for E2F site, 5Ј-CTCCACCTCAC-CCCCTAAAT-3Ј and 5Ј-GGGGGCGGGCGCAGGGGG-3Ј; primer pair for cAMP-response element (CRE) site, 5Ј-GCCCCCCTCCCGCTCCCATT-3Ј and 5Ј-TGGGGCTCTTCCTGGGCAGC-3Ј.
MCF7 cells were transiently transfected with either cyclin D1 Ϫ1745 or cyclin D1 Ϫ1745-ARF-response element deletion mutant reporter followed by treatment with estradiol for 45 min. The cells were cross-linked with formaldehyde buffer for 10 min at 37°C and followed the procedure as mentioned above.
RESULTS
Increased Cyclin D1 Abundance in Ink4a/Arf Deficient Cells.
The p16
INK4a tumor suppressor was initially defined through its ability to inhibit Ras-induced transformation (42) (Fig. 1B) . To determine whether reduced p16
INK4a levels were associated with increased abundance of cyclin D1 in vivo, we examined the tissues of mice genetically deficient for Ink4a/ Arf ϩ/Ϫ mice (40) . (These mice were generated by deleting exons 2 and 3 of the Cdkn2a locus and are functional knockouts for both p16 INK4a and p19 ARF genes, which share exons 2 and 3 of the Cdkn2a locus). Compared with the Ink4a/Arf wt mice, the Ink4a/Arf-deficient mice tissues showed 2-to 3-fold increased abundance of cyclin D1 protein (Fig. 1C) INK4a reduced S-phase by 40% (Fig. 2) , consistent with previous studies (31) , and p19 ARF reduced the S-phase fraction by 30%, consistent with previous studies in fibroblasts (43) .
Selective Repression of Cyclin D1 Promoter by p16 INK4a . Northern blot analysis of transfected and MACS-sorted MCF7 cells showed that p16
INK4a reduced cyclin D1 mRNA (Fig. 3A, right) .
p16
INK4a repressed the human cyclin D1 promoter, in a dose-dependent manner (Fig. 3A) and reduced cyclin D1 protein levels 40% (data not shown). To assess further the mechanism of cyclin D1 promoter transcriptional repression by p16
INK4a , the promoters of several cell cycle control genes were assessed. p16
INK4a did not inhibit the activity of the human c-fos promoter, consistent with a previous study in which p16
INK4a failed to repress the serum-response element of the c-fos promoter (42) . The pA 3 LUC vector reporter was unaffected by p16 INK4a , indicating that the effect was not mediated by a general effect on luciferase activity (Fig. 3A) . The viral cytomegalovirus (CMV) promoter was induced 3-fold by p16
INK4a . The cyclin E promoter was repressed by p16 INK4a (Fig. 3A) ; however, the cyclin A promoter was unaffected, and the p21 CIP1/WAF1 promoter was induced; thus p16
INK4a conveys promoter-specific regulatory effects. The p16
INK4a mutant defective in binding cdk4 (p16 INK4a -P114L; Ref. 36) repressed basal cyclin D1 promoter activity to a similar degree as p16
INK4a wt (Fig. 3B ). Thus the mechanism by which p16
INK4a represses basal activity of the cyclin D1 promoter appears to be independent of its cdk4-binding function. Because p16 INK4a failed to repress cyclin A, which is induced during S-phase entry, and the cdk4-binding-defective mutant repressed the cyclin D1 promoter, these findings raise the possibility that the effect of p16
INK4a on cyclin D1 promoter activity is not mediated indirectly through effects on DNA synthesis.
Cyclin D1 abundance regulates MCF7 cell cycle progression, making a determination of the effect of p16
INK4a independent of cell cycle complex. The ability of cyclin D1 to induce cell cycle progression is dependent upon the presence of the pRB protein, which is phosphorylated and inactivated by cyclin D1 kinase activity (44, 45) . pRB is inactivated by E1A and large T antigen (46) . We therefore assessed the effect of p16
INK4a on transcriptional regulation of the cyclin D1 (Fig. 4A) , while inducing the activity of the c-fos, c-jun, cdc25a, and p21 Cip1/WAF1 promoters. In contrast the CMV promoter was unaffected, and the cyclin E promoter was repressed (Fig. 4, A and B) . p16 INK4a Repression of the Cyclin D1 Promoter Requires the CRE/ATF-2-Binding Site in MCF7 Breast Epithelial Cells. Expression of cyclin D1 is induced by diverse signaling pathways in MCF7 cells including Ras, Wnt, and ErbB2 through distinct DNA sequences including a T cell factor (Tcf), E2F, and ATF/CRE site. Point mutation of the ATF/CRE site, but not the Tcf site, abrogated repression and resulted in a promoter fragment that was activated by p16
INK4a (Fig. 5A) . Mutation of the ATF/CRE site also abolished repression by p16
INK4a in the human SKBR3 breast cancer cell line (Fig. 5B) . As the CRE site of the cyclin D1 promoter binds CREB and ATF-2 protein in epithelial cells (35, 47) , we assessed the role of these proteins in regulating cyclin D1 promoter activity in MCF7 cells. ATF-2 inhibited cyclin D1 promoter activity 35-40%. In contrast, a DNA-binding-defective mutant of ATF-2 that dimerizes with AP-1 proteins and functions as a dominant-negative mutant of ATF-2 function, induced cyclin D1 (Fig. 5C) . CREB induced and a dominant-negative CREB mutant inhibited cyclin D1 promoter activity (Fig. 5C) CIP1 promoters in a dose-dependent manner, without affecting the activity of the viral CMV-LUC reporter (Fig. 6A) . Mutation of the Tcf site or the AP-1 and CRE site also did not reduce repression but rather enhanced repression by p19 ARF . p19 ARF transfection of MCF7 cells induced p53 and reduced cyclin D1 protein levels consistent with previous studies that p19 ARF functions in a genetic pathway that involves p53 (Refs. 49, 50; data not shown). Mutation of the ATF/CRE site that had abolished repression by p16
INK4a did not affect repression by p19 ARF (Fig. 6B ). p53 is capable of regulating gene expression either directly through consensus p53-response elements or through atypical response elements upon physical interaction with other proteins including WT1-Egr and nuclear receptors (51) (52) (53) . We scrutinized the sequences of the cyclin D1 promoter for DNA sequences that could potentially respond to p53 either directly or indirectly. In the absence of a consensus p53-response element, we mutated elements resembling an atypical p53-response element in the cyclin D1 promoter at Ϫ1137 (54). p19 ARFmediated repression was abrogated by deletion of the sequences, strongly suggesting a key role for this element in p19 ARF repression of cyclin D1 transcription (Fig. 6C) .
To further examine the role of p53 in the repression of the cyclin D1 promoter by p19 ARF , we performed ChIP assays in MCF7 cells. Oligonucleotides were generated for PCR amplification of the p53-response element of the mdm2 promoter as a form of positive control for the ChIP assays and to the cyclin D1 promoter CRE site, E2F site, and the ARF-response element. p53 bound the mdm2 promoter p53-response element in ChIP assays but was not identified at the cyclin D1 promoter CRE site. In contrast, p53 was contained within ChIP assays of the cyclin D1 promoter ARF-response element and E2F site (Fig. 7A) . Transfected cyclin D1 promoter recruited p53 to the ARFresponse element but did not bind p53 at the CRE site. Mutation of the cyclin D1 promoter ARF-response element abrogated p53-binding to the promoter in ChIP assays, strongly suggesting this site is required for p53 binding to the cyclin D1 promoter (Fig. 7) .
To determine whether p19 ARF repression of cyclin D1 transcription was unique to MCF7 cells, we assessed transcriptional regulation in the embryonal kidney cell line, 293T. Cyclin D1 and cyclin A promoter activity was repressed in a dose-dependent manner by p19 ARF , without affecting CMV promoter activity (Fig. 8A ). There was a modest induction of the c-Jun promoter (Fig. 8B) . p19 ARF repressed the p16
INK4a promoter (Fig. 8C ) consistent with previous findings that expression of p16
INK4a is high in ARF-null keratinocytes and bone marrow macrophages (55, 56) . 293T cells express E1A and large T, functionally inactivating the pRb and p53-response element. Consistent with other studies of ARF target genes, these findings suggest ARF repression of the cyclin D1 promoter may involve both p53-dependent and p53-independent signaling mechanisms. Together these studies demonstrate that the cyclin D1 gene is repressed by both reading frames transcribed from the INK4/ARF locus, and transcriptional repression is mediated through two distinct DNA sequences (Fig. 8D) . Fig. 7 . ChIP assays reveal p53 is bound to the cyclin D1 promoter. A, MCF7 cells were subjected to chromatin immuunoprecipitation assays. PCR using oligonucleotides flanking the cyclin D1 ARF-response element (ARE), and E2F site (E2F) revealed a band in samples immunoprecipitated with antibodies to p53 corresponding to the endogenous cyclin D1 promoter. CRE, cAMP-response element; LUC, luciferase. B, MCF7 cells transfected with a cyclin D1 promoter construct also indicated that p53 was bound to the ARF-response element (ARE) and E2F sites. C, p53 was not bound in MCF7 cells transfected with a mutant cyclin D1 promoter construct. 
DISCUSSION
The current studies provide evidence that the cyclin D1 gene is under transcriptional control by both components of the INK4a/ARF locus. Increased cyclin D1 protein abundance was observed in several Ink4a/Arf-deficient tissues, and both p16
INK4a and p19 ARF inhibited cyclin D1 abundance in MCF7 cells. The increased abundance of cyclin D1 in Ink4a/Arf-deficient tissues is consistent with recent findings of increased cyclin D1 levels in mammary tumors of transgenic mice induced by ErbB2 that were Ink4a/Arf-deficient (49) . The Ink4a/Arf deletions (23, 57, 58) , like cyclin D1 overexpression, correlate with poor outcome from tumors in patients and in mice. As the abundance of cyclin D1 is rate limiting in G 1 phase progression in mammary epithelial cells (7), regulation of cyclin D1 abundance by p16
INK4a and p19 ARF may contribute to the cell cycle control or tumor suppressor functions of these proteins.
Although p16 INK4a was originally identified as a protein binding to cdk4 that acts upstream of Rb to cause G 1 arrest (59), cdk4-binding independent functions of p16
INK4a contribute to cell cycle arrest (60, 61) . Several lines of evidence suggest the mechanism of transcriptional repression of the cyclin D1 promoter by p16
INK4a is specific and not an indirect effect of the expressed proteins on cell cycle control. First, p16
INK4a displayed promoter-selective function and was capable of either repressing (cyclin D1, Jun B) or activating (c-jun, cyclin A) transcription of specific target genes. Second, repression by p16 
